Uso de n-acetilcisteína para la prevención de la nefropatía inducida por contraste en ratas
Authors:
- M.F. İnCiMIM.F. İnCi
- İ. ŞalkIŞİ. Şalk
- Ü.E. VurdemÜVÜ.E. Vurdem
- R. İnCiRIR. İnCi
- 1 April 2012
- journal article
- Published by Elsevier in Actas Urológicas Españolas
- Vol. 36 (4) , 210-215
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrastCatheterization and Cardiovascular Interventions, 2003
- Antioxidant Vitamins and Enzymatic and Synthetic Oxygen-Derived Free Radical Scavengers in the Prevention and Treatment of Cardiovascular DiseaseHeart Disease, 2001
- Acetylcysteine and Nephrotoxic Effects of Radiographic Contrast Agents — A New Use for an Old DrugNew England Journal of Medicine, 2000
- Acute Renal Failure After Coronary InterventionThe American Journal of Medicine, 1997
- Endothelial Dysfunction and Cardiorenal Injury in Experimental Salt-Sensitive HypertensionCirculation, 1997
- Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive ratsJournal Of Hypertension, 1996
- N -Acetylcysteine in Combination With Nitroglycerin and Streptokinase for the Treatment of Evolving Acute Myocardial InfarctionCirculation, 1995
- Contrast nephropathy in azotemic diabetic patients undergoing coronary angiographyThe American Journal of Medicine, 1990
- Contrast Material-Induced Renal Failure in Patients with Diabetes Mellitus, Renal Insufficiency, or BothNew England Journal of Medicine, 1989
- Mechanism of the Renal Response to Contrast Medium in DogsInvestigative Radiology, 1983